Virginia Garner - CML survivor
|
Virginia is a 14 1/2 year CML survivor who was one of the first people in the world to take STI-571 (now called Gleevec) in the Phase 1 trial at UCLA with Dr. Charles Sawyers.
In 1997, Virginia was a high school English teacher near Los Angeles when she learned she had Chronic Myeloid Leukemia. She started a treatment with Interferon and Ara-C. On April 19, 1999, she was accepted into a clinical trial at UCLA and took the new drug STI-571. |
|
Side Effects of CML Therapy: What Can Be Done with Dr. Neil Shah VIDEO
by Healthvideo
Celebrate my life
by The National CML Society
by Healthvideo
Celebrate my life
by The National CML Society
Since 2001, Virginia and her husband Van have been raising money through the Leukemia & Lymphoma Society's Team in Training program. Now, Virginia and her husband have completed 11 marathons and raised over $240,000 for research in blood cancers. They are about to begin training and fundraising for the next marathon.
Aside from those marathons for the LLS, Virginia has completed 2 full marathons and about 28 half marathons. Also, her husband has completed 27 full marathons and 35 half marathons. His total running events, including smaller 5Ks and 10Ks, add up to over 100 kilometers! Finally, Virginia is glad to be strong and healthy enough to participate in these events, despite her Gleevec-induced anemia.
Relentless for a Cure
January 26, 2012, Leukemia & Lymphoma Society
Race brings out the best in survivors
June 17, 2011, adn.com
Aside from those marathons for the LLS, Virginia has completed 2 full marathons and about 28 half marathons. Also, her husband has completed 27 full marathons and 35 half marathons. His total running events, including smaller 5Ks and 10Ks, add up to over 100 kilometers! Finally, Virginia is glad to be strong and healthy enough to participate in these events, despite her Gleevec-induced anemia.
Relentless for a Cure
January 26, 2012, Leukemia & Lymphoma Society
Race brings out the best in survivors
June 17, 2011, adn.com
